By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPGY) To Present At The Cowen 35th Annual Healthcare Conference 2/25/2015 10:39:25 AM
Shire (SHPGY) Beefs Up Late-Stage Pipeline With $70 Million+ Meritage Pharma Buy 2/24/2015 6:03:09 AM
Shire (SHPGY) Calls For Improved Rare Disease Diagnosis On Rare Disease Day 2015 2/23/2015 11:42:24 AM
Shire (SHPGY) Completes Acquisition Of NPS Pharmaceuticals, Inc. (NPSP) 2/23/2015 7:00:05 AM
Endo Pharmaceuticals (ENDP) Rumored to be Battling Shire (SHPGY), Valeant (VRX) for Salix (SLXP)'s Affections 2/18/2015 7:09:32 AM
Look Out Valeant (VRX), Shire (SHPGY) Wants to Continue Spending Spree With Salix (SLXP) Bid 2/13/2015 6:28:45 AM
Shire (SHPGY) Delivers Record Revenues And Non GAAP Earnings Per ADS In 2014, And Enters 2015 With Strongest-Ever Pipeline 2/12/2015 11:02:26 AM
Shire (SHPGY) Release: Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First And Only Treatment Approved By The FDA For Adults With Moderate To Severe Binge Eating Disorder 2/2/2015 7:43:24 AM
U.S. Supreme Court Grants Shire (SHPGY) Petition 1/28/2015 7:57:50 AM
Shire (SHPGY)'s Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation For The Treatment Of Neurocognitive Decline Associated With Hunter Syndrome 1/26/2015 7:29:07 AM